Company profile: BAC
1.1 - Company Overview
Company description
- Provider of affinity purification products and services for the biopharmaceutical market, with CaptureSelect products used from drug discovery to manufacturing of biopharmaceuticals, based on a proprietary platform integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BAC
Nautilus Biotechnology
HQ: United States
Website
- Description: Provider of a high-throughput, low-cost proteome analysis platform enabling single-molecule protein counting and comprehensive quantification across the human proteome. Offers the Nautilus Proteome Analysis Platform, the PrISM theoretical framework, and multi-affinity probes to analyze up to 10 billion protein molecules per run with an expected dynamic range spanning up to 9 orders of magnitude.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nautilus Biotechnology company profile →
NanoMR
HQ: United States
Website
- Description: Provider of blood diagnostic devices and an immunomagnetic capture system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower, enabling simultaneous targeting of multiple cell types, including bacteria and fungi from bloodstream infections, as well as specific cells such as circulating tumor and fetal cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoMR company profile →
Anterios
HQ: United States
Website
- Description: Provider of botulinum-based prescription products for aesthetic medicine and dermatology and nanotechnology-based delivery systems for administering drugs and cosmetics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anterios company profile →
ThermoGenesis
HQ: United States
Website
- Description: Provider of automated technologies for cell-based therapeutics and bioprocessing, including BioArchive for computer-controlled preservation of cells with traceability; X-LAB for rapid, closed-system mononuclear cell isolation; PXP-1000 for automated cord blood stem cell processing; 3D Bag Set for buffy coat transfer with sterile cryoprotectant addition for long-term storage; and cleanroom and wet lab facilities for life science startups.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ThermoGenesis company profile →
3D Bio-Tissues
HQ: United Kingdom
Website
- Description: Provider of bio-equivalent tissues for clinical and cellular agriculture, including 3DBT corneas engineered to match human donor corneas, Tissue Templating Technology for structured, scalable tissues without animal components, City-Mix culture media supplement to enhance cell performance, and Etsyl, a lipopeptide that stimulates collagen production for cosmetic and pharmacological use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3D Bio-Tissues company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BAC
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BAC
2.2 - Growth funds investing in similar companies to BAC
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BAC
4.2 - Public trading comparable groups for BAC
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →